Issue 12, 2015

Synthesis of Au yolk/LDH shell nanoparticles as anticancer vehicles

Abstract

In this paper, anticancer drug methotrexate (MTX) is applied as a coupling agent to fabricate Au@SiO2 core–shell structures for the first time. Then, a novel kind of Au yolk/LDH shell nanoparticles is obtained by using Au@SiO2 as the template. Finally, the in vitro cytotoxicity is examined and the result indicates that the yolk/shell nanovehicles loaded with MTX exhibit superior anticancer efficacy, compared to the free drug.

Graphical abstract: Synthesis of Au yolk/LDH shell nanoparticles as anticancer vehicles

Supplementary files

Article information

Article type
Communication
Submitted
19 Nov 2014
Accepted
22 Dec 2014
First published
22 Dec 2014

RSC Adv., 2015,5, 8689-8692

Synthesis of Au yolk/LDH shell nanoparticles as anticancer vehicles

X. Huo, C. Dai, S. Li and X. Li, RSC Adv., 2015, 5, 8689 DOI: 10.1039/C4RA14585B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements